News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
149,084 Results
Type
Article (3095)
Company Profile (111)
Press Release (145878)
Section
Business (47487)
Career Advice (88)
Deals (8426)
Drug Delivery (3)
Drug Development (29319)
Employer Resources (12)
FDA (2376)
Job Trends (3207)
News (86383)
Policy (5619)
Tag
Academia (142)
Allergies (21)
Alliances (10615)
Alzheimer's disease (268)
Approvals (2381)
Bankruptcy (48)
Best Places to Work (2830)
Biotechnology (74)
Breast cancer (33)
Cancer (362)
Career advice (80)
CAR-T (23)
Cell therapy (62)
Clinical research (24853)
Collaboration (112)
Compensation (137)
COVID-19 (348)
C-suite (40)
Data (475)
Diabetes (41)
Diagnostics (300)
Earnings (20791)
Events (30478)
Executive appointments (139)
FDA (2548)
Featured Employer (22)
Funding (89)
GLP-1 (115)
Government (373)
Healthcare (1680)
Infectious disease (363)
Inflammatory bowel disease (32)
IPO (5189)
Job creations (508)
Job search strategy (75)
Layoffs (30)
Legal (692)
Lung cancer (61)
Lymphoma (29)
Manufacturing (51)
Medical device (289)
Medtech (289)
Mergers & acquisitions (3338)
Metabolic disorders (114)
Neuroscience (350)
NextGen Class of 2024 (696)
Non-profit (178)
Northern California (648)
Obesity (51)
Parkinson's disease (21)
Patents (23)
People (14720)
Pharmaceutical (38)
Phase I (7299)
Phase II (11325)
Phase III (8169)
Pipeline (195)
Postmarket research (478)
Preclinical (2664)
Radiopharmaceuticals (90)
Rare diseases (51)
Real estate (931)
Regulatory (4838)
Research institute (182)
Schizophrenia (25)
Southern California (523)
Startups (713)
United States (4842)
Vaccines (64)
Date
Today (35)
Last 7 days (175)
Last 30 days (697)
Last 365 days (10777)
2024 (10725)
2023 (12367)
2022 (14237)
2021 (16004)
2020 (13727)
2019 (8837)
2018 (6248)
2017 (8072)
2016 (6574)
2015 (8393)
2014 (6322)
2013 (4517)
2012 (4446)
2011 (4448)
2010 (4453)
Location
Africa (78)
Asia (11429)
Australia (1252)
California (1348)
Canada (346)
China (156)
Colorado (37)
Connecticut (51)
Delaware (43)
Europe (21041)
Florida (143)
Georgia (42)
Illinois (56)
Indiana (34)
Kansas (46)
Maryland (150)
Massachusetts (1067)
Michigan (28)
Minnesota (52)
New Jersey (490)
New York (490)
North Carolina (250)
Northern California (648)
Ohio (40)
Pennsylvania (248)
South America (122)
Southern California (523)
Texas (135)
Utah (22)
Virginia (25)
Washington State (76)
149,084 Results for "hillhurst biopharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Hillhurst Biopharmaceuticals Receives NIH Heal Initiative Award for Development of HBI-201 in Pain
Hillhurst Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing liquid drug products containing therapeutic gases, announced the award of an up to $5 million HEAL Initiative grant from the National Institutes of Health.
November 7, 2023
·
2 min read
Biotech Beach
Hillhurst Biopharma Completes Seed Financing to Advance Clinical Development
Hillhurst Biopharmaceuticals, Inc. announced the completion of a financing that, together with non-dilutive sources, funds Phase 2a clinical studies in sickle cell disease and in a second clinical indication.
December 20, 2023
·
2 min read
Drug Development
HILLHURST BIOPHARMACEUTICALS RECEIVES $3 MILLION IN NIH SBIR FUNDING FOR PHASE 2A CLINICAL STUDY IN SICKLE CELL DISEASE
Hillhurst Biopharmaceuticals, Inc. today announced the award of an approximately $3 million Phase 2b SBIR grant from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.
September 20, 2023
·
2 min read
Drug Development
HILLHURST BIOPHARMACEUTICALS ANNOUNCES COMPLETION OF LAST PATIENT LAST VISIT IN PHASE 1 CLINICAL TRIAL OF HBI-002
Hillhurst Biopharmaceuticals, Inc. (“Hillhurst”) today announced that the last participant has completed the study protocol of its U.S. Phase 1 clinical trial of HBI-002, an oral low dose carbon monoxide (CO) therapeutic candidate.
May 23, 2023
·
2 min read
Press Releases
Angitia Biopharmaceuticals Announces $120 Million Series C Financing
December 11, 2024
·
4 min read
Press Releases
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
December 23, 2024
·
13 min read
Press Releases
VectorBuilder and Sartorius Sign Strategic Cooperation Agreement to Advance Biopharmaceutical Innovation
November 27, 2024
·
2 min read
Drug Development
Hillhurst Biopharmaceuticals Receives Study May Proceed Letter From US FDA to Initiate Phase 1 Clinical Trial of HBI-002
Hillhurst Biopharmaceuticals, Inc. (“Hillhurst”), a clinical-stage biopharmaceutical company focused on developing oral therapies enabling the therapeutic use of low dose carbon monoxide (CO), today announced that the company has received a Study May Proceed Letter from the U.S. Food and Drug Administration (FDA) permitting the company to begin its Phase 1 trial for HBI-002,
April 27, 2021
·
2 min read
Press Releases
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer
December 11, 2024
·
4 min read
Press Releases
Biopharmaceuticals Market to Hit US$ 654.76 Billion by 2030, Coherent Market Insights
November 13, 2024
·
1 min read
1 of 14,909
Next